No shortage on file

POTASSIUM PHOSPHATE MONOBASIC INJECTION

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of POTASSIUM PHOSPHATE MONOBASIC INJECTION in Canada?

No. There is no current shortage of POTASSIUM PHOSPHATE MONOBASIC INJECTION 176MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-13

DIN

00711306

Strength

176MG

Dosage Form

SOLUTION LIQUID

Route

INTRAVENOUS

Active Ingredient

POTASSIUM PHOSPHATE MONOBASIC

See all POTASSIUM PHOSPHATE MONOBASIC products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History

2026-10-06

Resolved

Other (Please describe in comments)

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929